Abstract
On the basis of different evidences, androstadienone, a steroid compound produced in the armpit, has been proposed as a human pheromone, although its physiological levels appear too low to induce a response under experimental conditions. For this reason, the majority of researchers in this area puts into question the “legitimacy” of androstadienone, and prefers to consider the axillary extracts in its entirety, like a sort of “medicinal tea”, the components of which still remain to be identified, but that taken together may induce a response, or function as a carrier of other active substances. Another option is that androstadienone acts with varying degrees of potency and, at lower concentrations, according to the context and to specific behavioral situations.
The aim of this paper is to review all relevant data regarding androstadienone, in order to ascertain whether it may be considered a physiological pheromone and, as such, a possible target of future modulators of some human behaviors.
Keywords: Pheromones, humans, androstadienone, hormones, behaviors, mood, emotions, axillary organ, Pheromone Receptors, steroidal secretions
Current Medicinal Chemistry
Title: Is Androstadienone a Putative Human Pheromone?
Volume: 18 Issue: 8
Author(s): D. Marazziti, P. Torri, S. Baroni, M. Catena Dell'Osso, G. Consoli and V. Boncinelli
Affiliation:
Keywords: Pheromones, humans, androstadienone, hormones, behaviors, mood, emotions, axillary organ, Pheromone Receptors, steroidal secretions
Abstract: On the basis of different evidences, androstadienone, a steroid compound produced in the armpit, has been proposed as a human pheromone, although its physiological levels appear too low to induce a response under experimental conditions. For this reason, the majority of researchers in this area puts into question the “legitimacy” of androstadienone, and prefers to consider the axillary extracts in its entirety, like a sort of “medicinal tea”, the components of which still remain to be identified, but that taken together may induce a response, or function as a carrier of other active substances. Another option is that androstadienone acts with varying degrees of potency and, at lower concentrations, according to the context and to specific behavioral situations.
The aim of this paper is to review all relevant data regarding androstadienone, in order to ascertain whether it may be considered a physiological pheromone and, as such, a possible target of future modulators of some human behaviors.
Export Options
About this article
Cite this article as:
Marazziti D., Torri P., Baroni S., Catena Dell'Osso M., Consoli G. and Boncinelli V., Is Androstadienone a Putative Human Pheromone?, Current Medicinal Chemistry 2011; 18 (8) . https://dx.doi.org/10.2174/092986711795029654
DOI https://dx.doi.org/10.2174/092986711795029654 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Maternal Sodium Valproate Exposure Alters Neuroendocrine-Cytokines and Oxido-inflammatory Axes in Neonatal Albino Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Discovery of New Cardiovascular Hormones for the Treatment of Congestive Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets The Hypothalamus and Obesity
Recent Patents on CNS Drug Discovery (Discontinued) Single Nucleotide Polymorphism in FTO rs9939609 and Obesity Among Asians and Caucasians: A Meta-Analysis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Hypothalamus and Obesity
Current Drug Targets The Concept of Depression as a Dysfunction of the Immune System
Current Immunology Reviews (Discontinued) Approach to the Patient with Subclinical Cushing’s Syndrome
Current Pharmaceutical Design From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases
Current Drug Targets - CNS & Neurological Disorders Chest Pain, Panic Disorder and Coronary Artery Disease: A Systematic Review
CNS & Neurological Disorders - Drug Targets Neuroprotection by vitamin C against ethanol -induced neuroinflammation associated neurodegeneration in developing rat brain
CNS & Neurological Disorders - Drug Targets Nociceptin/Orphanin FQ Peptide Receptor as a Therapeutic Target for Obesity
Mini-Reviews in Medicinal Chemistry N-3 (Omega-3) Polyunsaturated Fatty Acids in the Pathophysiology and Treatment of Depression: Pre-Clinical Evidence
CNS & Neurological Disorders - Drug Targets The Realization of the Brain-Gut Interactions with Corticotropin-Releasing Factor and Glucocorticoids
Current Neuropharmacology Modulating Fatty Acid Metabolism and the AMP-Activated Protein Kinase Pathway as a Target for Obesity Therapy
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Fibromyalgia
Current Rheumatology Reviews Uterine Function: From Normal to Polycystic Ovarian Syndrome Alterations
Current Medicinal Chemistry Pharmacogenetics of Obesity Drug Therapy
Current Molecular Medicine A Review on Novel Ligand Targeted Delivery for Cardiovascular Disorder
Current Drug Delivery Cell Clocks and Neuronal Networks: Neuron Ticking and Synchronization in Aging and Aging-Related Neurodegenerative Disease
Current Alzheimer Research